ArticleAmerican journal of epidemiology2011
Comparability of different methods for estimating influenza infection rates over a single epidemic wave.
Article in American journal of epidemiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.Influenza and other respiratory viruses · 2017Guideline
- Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions.The Cochrane database of systematic reviews · 2016Pooled it
- Review Article: The Fraction of Influenza Virus Infections That Are Asymptomatic: A Systematic Review and Meta-analysis.Epidemiology (Cambridge, Mass.) · 2015Pooled it
- Natural attack rate of influenza in unvaccinated children and adults: a meta-regression analysis.BMC infectious diseases · 2014Pooled it
- Cross-sectional telephone surveys as a tool to study epidemiological factors and monitor seasonal influenza activity in Malta.BMC public health · 2021Article
- A Systematic Review and Meta-Analysis of Seasonal Influenza Vaccination of Health Workers.Vaccines · 2021Review
- Decline in influenza cases in Mexico after the implementation of public health measures for COVID-19.Scientific reports · 2021Article
- Using serological measures to estimate influenza incidence in the presence of secular trends in exposure and immuno-modulation of antibody response.Influenza and other respiratory viruses · 2021Article
- Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.Emerging infectious diseases · 2020Article
- Estimating the Size of a COVID-19 Epidemic from Surveillance Systems.Epidemiology (Cambridge, Mass.) · 2020Article
- Vitamin D Deficiency is Associated with Increased Use of Antimicrobials among Preschool Girls in Ethiopia.Nutrients · 2019Article
- Validation of a Natural Language Processing Algorithm for Detecting Infectious Disease Symptoms in Primary Care Electronic Medical Records in Singapore.JMIR medical informatics · 2018Article
- Public preferences for interventions to prevent emerging infectious disease threats: a discrete choice experiment.BMJ open · 2018Article
- Individual and Population Trajectories of Influenza Antibody Titers Over Multiple Seasons in a Tropical Country.American journal of epidemiology · 2018Article
- Severity and burden of hand, foot and mouth disease in Asia: a modelling study.BMJ global health · 2018Article
- Rethinking thresholds for serological evidence of influenza virus infection.Influenza and other respiratory viruses · 2017Article
- Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America.Human vaccines & immunotherapeutics · 2017Article
- Quantifying homologous and heterologous antibody titre rises after influenza virus infection.Epidemiology and infection · 2016Article
- Interpreting Seroepidemiologic Studies of Influenza in a Context of Nonbracketing Sera.Epidemiology (Cambridge, Mass.) · 2016Article
- The Global Influenza Hospital Surveillance Network (GIHSN): a new platform to describe the epidemiology of severe influenza.Influenza and other respiratory viruses · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Estimation of influenza infection rates is important for determination of the extent of epidemic spread and for calculation of severity indicators. The authors compared estimated infection rates from paired and cross-sectional serologic surveys, rates of influenza like illness (ILI) obtained from sentinel general practitioners (GPs), and ILI samples that tested positive for influenza using data from similar periods collected during the 2009 H1N1 epidemic in Singapore. The authors performed sensitivity analyses to assess the robustness of estimates to input parameter uncertainties, and they determined sample sizes required for differing levels of precision. Estimates from paired seroconversion were 17% (95% Bayesian credible interval (BCI): 14, 20), higher than those from cross-sectional serology (12%, 95% BCI: 9, 17). Adjusted ILI estimates were 15% (95% BCI: 10, 25), and estimates computed from ILI and laboratory data were 12% (95% BCI: 8, 18). Serologic estimates were least sensitive to the risk of input parameter misspecification. ILI-based estimates were more sensitive to parameter misspecification, though this was lessened by incorporation of laboratory data. Obtaining a 5-percentage-point spread for the 95% confidence interval in infection rates would require more than 1,000 participants per serologic study, a sentinel network of 90 GPs, or 50 GPs when combined with laboratory samples. The various types of estimates will provide comparable findings if accurate input parameters can be obtained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.